Skip to Content

Coronavirus

Three-dose Covid-19 vaccine produces strong immune response in children ages 6 months to 5 years, Pfizer and BioNTech say

By Nadia Kounang, CNN Three child-size doses of the Pfizer/BioNTech Covid-19 vaccine appeared to be safe and showed a strong immune response in children ages 6 months to 5 years, the companies said Monday. The vaccine makers said they will finish submitting the trial data to the US Food and Drug Administration this week. The

Continue Reading

CDC signs off on boosters for 5-11-year-olds

By Jen Christensen, CNN The US Centers for Disease Control and Prevention signed off on boosters for 5- to 11-year-olds following the independent vaccine advisers recommendation for an additional dose of the Pfizer/BioNTech Covid-19 vaccine following a primary series. The CDC’s vaccine advisers voted 11-1, with 1 abstention Thursday to support recommending a booster dose,

Continue Reading